Sky Century Investment SKYI
OTC SKYI
$0.15 +0.05 (+50.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Sky Century Investment (SKYI) Change in Cash (2012 - 2026)

Sky Century Investment (SKYI) posted quarterly Change in Cash of -$3096.0 for Q2 2026, down 127.37% year-over-year from $11312.0 in Q2 2025, and down 207.02% quarter-over-quarter from $2893.0 in Q1 2026.

Sky Century Investment (SKYI) Change in Cash (2012 - 2026) Analysis & Trends

Sky Century Investment (SKYI) has reported Change in Cash for 5 consecutive years, with -$3096.0 the latest figure, recorded in Q2 2026.

  • In Q2 2026, Change in Cash fell 127.37% year-over-year to -$3096.0; the TTM figure through May 2026 stood at -$11048.0 (down 197.67% YoY), while the FY2025 annual figure was $477.0, changed N/A from the prior year.
  • Change in Cash retreated to -$3096.0 in Q2 2026 per SKYI's latest filing, from $2893.0 in the prior quarter.
  • Across five years, Change in Cash topped out at $11312.0 in Q2 2025 and bottomed at -$10835.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -86.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -465.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -881.03 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 523.50 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -915.70 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 64.40 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 102.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Sky Century Investment 393,547.71 393,283.71 26,045.00 -3,096.00

Historic Data

Download Data
DateValue
May 31, 2026 -3,096.00
Feb 28, 2026 2,893.00
Nov 30, 2025 -10.00
Aug 31, 2025 -10,835.00
May 31, 2025 11,312.00
Feb 28, 2014 -5,050.00
Nov 30, 2013 5,086.00
Aug 31, 2013 325.00
Feb 28, 2013 -200.00
Nov 30, 2012 -500.00
Aug 31, 2012 -4,146.00